New treatment option for Persistent Postural Perceptual Dizziness
Official title Using Glialia for Treating Persistent Perceptual Postural Dizziness
ClinicalTrials.gov ID: NCT06741358
What this study is testing
- What it's testing
- This pilot study will involve 30 participants recruited from the Santa Lucia Foundation IRCCS, including 20 patients diagnosed with Persistent Perceptual Postural Dizziness (PPPD), and might or might not have previously contracted Sars Cov2 infection. They who will be randomly assigned to receive either the Glialia supplement or placebo.
- Phase 4: studies an already-approved treatment
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- for all groups: -Age between 18 and 65 years. for the PPPD-glialia group:
- Diagnosis of PPPD;
- Recovery from COVID-19 infection or absence of previous infection. for the PPPD-placebo group:
- Diagnosis of PPPD;
- Recovery from COVID-19 infection or absence of previous infection (matched to the PPPD-glialia group).
You likely can't join if
- for all PPPD-group:
- Presence of concurrent neurological and otological disorders other than PPPD;
- Pregnant women. Inclusion criteria for the control group: -Previous COVID-19 infection (matched for timing to the PPPD-glialia group). Exclusion...
- Presence of neurological and otological disorders;
- Pregnant women.
The study team makes the final eligibility decision.
Where it's taking place
- Rome, RM, Italy
Compensation & support
Some study costs may be covered.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rome, RM, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.